AI helps development of treatment for psychiatric medications
Artificial Intelligence is having a broad impact on research and development and this was a focus of a conference held in Israel this week called the Tel-Aviv Sparks Innovation Summit. One participant was Dr. Nissim Peretz, the CEO of Itay & Beyond, a company that synthesizes brain cells from urine samples to test psychiatric medications using AI. Their technology aims to eliminate the exhausting trial-and-error process of psychiatric drug matching. (photo: courtesy)
See omnystudio.com/listener for privacy information.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.